磷酸二酯酶同工酶：新型抗哮喘药物的分子靶点。 - Suppr

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

作者信息

Torphy T J

机构信息

Department of Pulmonary Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939, USA.

出版信息

Am J Respir Crit Care Med. 1998 Feb;157(2):351-70. doi: 10.1164/ajrccm.157.2.9708012.

DOI:10.1164/ajrccm.157.2.9708012

PMID:9476844

Abstract

摘要

相似文献

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

Am J Respir Crit Care Med. 1998 Feb;157(2):351-70. doi: 10.1164/ajrccm.157.2.9708012.

[Cyclic nucleotides phosphodiesterases inhibitors].

Nihon Rinsho. 1991 Sep;49(9):1993-8.

[Regulation of the phosphodiesterase activity of cyclic nucleotides (new endogenous regulators)].

Vestn Akad Med Nauk SSSR. 1982(9):64-9.

Chemical evolution of autotaxin inhibitors.

Chem Rev. 2012 May 9;112(5):2593-603. doi: 10.1021/cr2003213. Epub 2012 Feb 15.

Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes.

Biochemistry. 1993 May 18;32(19):4975-8. doi: 10.1021/bi00070a001.

Purification and kinetic properties of cardiac calmodulin dependent cyclic nucleotide PDE (PDE-I).

Biochem Soc Trans. 1996 May;24(2):320S. doi: 10.1042/bst024320s.

Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.

Mol Pharmacol. 2003 Jun;63(6):1209-11. doi: 10.1124/mol.63.6.1209.

Chemotherapeutic potential of phosphodiesterase inhibitors.

Curr Opin Chem Biol. 1998 Aug;2(4):472-81. doi: 10.1016/s1367-5931(98)80123-3.

Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?

J Lab Clin Med. 1993 Jan;121(1):15-7.

Therapeutic potential of selective PDE inhibitors in asthma.

Pulm Pharmacol Ther. 1999;12(2):123-9. doi: 10.1006/pupt.1999.0182.

引用本文的文献

A systematic review of novel Phosphodiesterase-4 inhibitors in the treatment of psoriasis.

Inflamm Res. 2025 Aug 30;74(1):116. doi: 10.1007/s00011-025-02073-w.

New Polyketide and Butenolide Derivatives from the Mangrove Fungus SCSIO 41433.

Mar Drugs. 2025 Jun 13;23(6):251. doi: 10.3390/md23060251.

Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.

Acta Pharm Sin B. 2024 Apr;14(4):1726-1741. doi: 10.1016/j.apsb.2024.01.012. Epub 2024 Jan 22.

Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers.

Int J Mol Sci. 2023 Apr 20;24(8):7617. doi: 10.3390/ijms24087617.

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis.

Front Pharmacol. 2023 Feb 14;14:1111393. doi: 10.3389/fphar.2023.1111393. eCollection 2023.

Circulating MicroRNAs Expression Profile in Lung Inflammation: A Preliminary Study.

J Clin Med. 2022 Sep 16;11(18):5446. doi: 10.3390/jcm11185446.

The effects of BRL-50481 on ovalbumin-induced asthmatic lung inflammation exacerbated by co-exposure to Asian sand dust in the murine model.

Arch Pharm Res. 2022 Jan;45(1):51-62. doi: 10.1007/s12272-021-01367-x. Epub 2022 Jan 4.

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk.

Front Pharmacol. 2021 Oct 5;12:748798. doi: 10.3389/fphar.2021.748798. eCollection 2021.

Towards a Molecular Understanding of Cation-Anion Interactions and Self-aggregation of Adeninate Salts in DMSO by NMR and UV Spectroscopy and Crystallography.

Chemphyschem. 2021 Oct 5;22(19):2025-2033. doi: 10.1002/cphc.202100098. Epub 2021 Aug 8.

Phosphodiesterase-4 Inhibition in Psoriasis.

Psoriasis (Auckl). 2021 Mar 17;11:21-29. doi: 10.2147/PTT.S303634. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献